Regeneron Announces Investor Conference Presentation

Rhea-AI Summary

Regeneron (NASDAQ: REGN) will webcast management participation at the Barclays 28th Annual Global Healthcare Conference at 9:00 a.m. ET on Tuesday, March 10, 2026. The session is available from the company’s Investors & Media page, with a replay and transcript archived for at least 30 days.

TARRYTOWN, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation at the Barclays 28th Annual Global Healthcare Conference at 9:00 a.m. ET on Tuesday, March 10, 2026.

The session may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. A replay and transcript of the webcast will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier
of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com        

FAQ

When is Regeneron (REGN) presenting at the Barclays 28th Annual Global Healthcare Conference?

Regeneron will present live at the Barclays conference at 9:00 a.m. ET on Tuesday, March 10, 2026. According to the company, the session will be webcast and available on the Investors & Media page, with replay and transcript archived for at least 30 days.

How can investors access the Regeneron (REGN) webcast on March 10, 2026?

Investors can access the live webcast via Regeneron’s Investors & Media page on the company website using the events-and-presentations link. According to the company, a replay and transcript will be archived on the website for at least 30 days following the session.

Will there be a replay or transcript for Regeneron (REGN) after the Barclays presentation?

Yes. Regeneron will provide a replay and transcript archived on its website for at least 30 days post-event. According to the company, materials will appear on the Investors & Media page after the March 10, 2026 presentation and remain archived for that period.

What topics will Regeneron (REGN) cover in its March 10, 2026 Barclays presentation?

The company did not specify presentation topics in the announcement for the March 10, 2026 session. According to the company, investors should watch the webcast or consult the archived transcript on the Investors & Media page for full session details.

Is the Regeneron (REGN) Barclays webcast free and open to the public?

Yes. The webcast is accessible via the company website; no registration details were disclosed in the announcement. According to the company, the session may be accessed from the Investors & Media page; viewers can use the link provided without further purchase information.